BRPI1013671A2 - método para o diagnóstico de endometriose e kit de diagnóstico para endometriose - Google Patents

método para o diagnóstico de endometriose e kit de diagnóstico para endometriose

Info

Publication number
BRPI1013671A2
BRPI1013671A2 BRPI1013671A BRPI1013671A BRPI1013671A2 BR PI1013671 A2 BRPI1013671 A2 BR PI1013671A2 BR PI1013671 A BRPI1013671 A BR PI1013671A BR PI1013671 A BRPI1013671 A BR PI1013671A BR PI1013671 A2 BRPI1013671 A2 BR PI1013671A2
Authority
BR
Brazil
Prior art keywords
endometriosis
diagnostic kit
diagnosing
diagnosing endometriosis
diagnostic
Prior art date
Application number
BRPI1013671A
Other languages
English (en)
Inventor
Masaharu Ito
Motowo Nabeta
Yasuhito Abe
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of BRPI1013671A2 publication Critical patent/BRPI1013671A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPI1013671A 2009-03-06 2010-02-23 método para o diagnóstico de endometriose e kit de diagnóstico para endometriose BRPI1013671A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009054082 2009-03-06
JP2009223493 2009-09-28
PCT/JP2010/052738 WO2010101047A1 (ja) 2009-03-06 2010-02-23 子宮内膜症の判定方法、および子宮内膜症の診断用キット

Publications (1)

Publication Number Publication Date
BRPI1013671A2 true BRPI1013671A2 (pt) 2016-04-26

Family

ID=42709607

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1013671A BRPI1013671A2 (pt) 2009-03-06 2010-02-23 método para o diagnóstico de endometriose e kit de diagnóstico para endometriose

Country Status (12)

Country Link
US (1) US20120045779A1 (pt)
EP (1) EP2405266A4 (pt)
JP (1) JPWO2010101047A1 (pt)
KR (1) KR20110137337A (pt)
CN (1) CN102341704A (pt)
AU (1) AU2010219820A1 (pt)
BR (1) BRPI1013671A2 (pt)
CA (1) CA2753524A1 (pt)
MX (1) MX2011009299A (pt)
RU (1) RU2011140471A (pt)
WO (1) WO2010101047A1 (pt)
ZA (1) ZA201107283B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5686431B2 (ja) * 2011-01-28 2015-03-18 学校法人 京都産業大学 卵巣癌の検出方法、並びに、キット
US20150004633A1 (en) * 2012-02-07 2015-01-01 Quest Diagnostics Investments Incorporated Assays and methods for the diagnosis of ovarian cancer
DE102012002929A1 (de) 2012-02-14 2013-08-14 Jürgen Lewald Minimalinvasives Verfahren für die Diagnose und die Therapieverlaufskontrolle der Endometriose
EP3077816B1 (en) * 2013-12-05 2021-03-24 Biothera, Inc. Beta-glucan assay methods
GB201403489D0 (en) * 2014-02-27 2014-04-16 Univ London Queen Mary Biomarkers for endometriosis
CN106872593B (zh) * 2017-02-04 2021-05-04 江西省妇幼保健院 溶血磷脂酸作为标志物在检测子宫内膜异位症中的应用
US11815435B2 (en) 2017-02-24 2023-11-14 Hibercell, Inc. Beta glucan immunopharmacodynamics
CN107991493B (zh) * 2017-11-22 2020-03-31 中国医科大学附属第一医院 抗eno1自身抗体在对ait孕妇筛查和预测流产风险中的应用
CN111721938B (zh) * 2019-03-29 2022-11-25 北京九强生物技术股份有限公司 糖链抗原125胶乳免疫比浊试剂盒
JP7315780B2 (ja) * 2019-07-22 2023-07-26 エフ． ホフマン－ラ ロシュ アーゲー 子宮内膜症の非侵襲的診断のための血液バイオマーカーとしてのサブスタンスｐ
CN113325183B (zh) * 2021-06-01 2022-11-15 中国医学科学院北京协和医院 一种用于鉴别诊断em/fem的试剂盒
CN113244368B (zh) * 2021-06-15 2021-12-28 黑龙江中医药大学 多肽在制备治疗子宫内膜异位症的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062959A2 (en) 2000-02-25 2001-08-30 Metriogene Biosciences Inc. Endometriosis-related markers and uses thereof
JP2005049343A (ja) 2003-07-14 2005-02-24 Yoshinori Kosugi 子宮内膜症関連疾患の診断方法
EP1668371B1 (en) 2003-09-24 2012-05-09 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis using tfpi-2 protein
US20080031898A1 (en) * 2004-03-26 2008-02-07 David Nathaniel E Compositions and methods to increase the effect of a neurotoxin treatment
US20100055724A1 (en) * 2007-01-26 2010-03-04 University Of Louisville Research Foundation, Inc. Methods of detecting autoantibodies for diagnosing and characterizing disorders
CN101334410B (zh) * 2007-06-26 2013-03-27 沙桂华 一种检测子宫内膜异位症的试剂盒

Also Published As

Publication number Publication date
EP2405266A4 (en) 2012-07-25
EP2405266A1 (en) 2012-01-11
WO2010101047A1 (ja) 2010-09-10
KR20110137337A (ko) 2011-12-22
AU2010219820A1 (en) 2011-09-15
MX2011009299A (es) 2011-10-11
US20120045779A1 (en) 2012-02-23
ZA201107283B (en) 2012-12-27
RU2011140471A (ru) 2013-04-20
JPWO2010101047A1 (ja) 2012-09-06
CA2753524A1 (en) 2010-09-10
CN102341704A (zh) 2012-02-01

Similar Documents

Publication Publication Date Title
BRPI1013671A2 (pt) método para o diagnóstico de endometriose e kit de diagnóstico para endometriose
IL233095A0 (en) Ratio based biomarkers and methods of use thereof
BR112012007730A2 (pt) planejamento e monitoramento de testes de formação
BRPI0910608A2 (pt) métodos e sistemas para avaliar resultados clínicos
BR112013012460A2 (pt) "kit de diagnóstico para biomarcadores de benefício de saúde vaginal e método para a detecção de biomarcadoeres de benefício de saúde vaginal"
PT3151354T (pt) Alojamento e dispositivo de selagem
AT10812U2 (de) Prüfstandsanordnung
BRPI1015922A2 (pt) sistemas e métodos para testar analitos
AT10813U2 (de) Prüfstandsanordnung
GB0906215D0 (en) Diagnostic test
EP2497629A4 (en) REIFENFLICKSET
IL215874A (en) Inspection method for lithography
BR112012014996A2 (pt) método diagnóstico baseado em reaaranjo somaticamente adquirido
EP2467169A4 (en) IN VIVO SCREENING ASSAYS
BR112012004102A2 (pt) métodos de ensaio
EP2497059A4 (en) SATISFACTION INDICATOR
DK2930516T3 (da) Graviditetstest
BRPI0920562A2 (pt) aparelho indicador de posição de válvula
BRPI1006174A2 (pt) metodo de teste e dispositivo de teste
BRPI0918048A2 (pt) configuração de dispositivo adaptado para testes
BRPI1011846A2 (pt) método de imunoensaio de aglutinação homogêneo e kit para este método
EP2440937A4 (en) A diagnostic method
AT508477A3 (de) Rohrleitungsinspektionsgerät
DK2245463T3 (da) Diagnostisk fremgangsmåde
BRPI0918279A2 (pt) método de diagnóstico e kit de diagnóstico para dermatomiosite

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]